I-COPE Study: Opioid Use and Pain Management in Older Adults (I-COPE)
Primary Purpose
Chronic Pain, Opioids, Opioid-use Disorder
Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
I-COPE
Sponsored by
About this trial
This is an interventional health services research trial for Chronic Pain focused on measuring older adults, electronic health record, chronic pain, opioid use disorder
Eligibility Criteria
Inclusion Criteria:
- age over 65 years AND
- receives care at a participating clinical site AND
- history of chronic pain AND/OR
- opioid prescription in the last 28 days AND/OR
- history of opioid use disorder AND/OR
Exclusion Criteria:
-
Sites / Locations
- University of Chicago MedicineRecruiting
- Access Community Health NetworkRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
I-COPE Intervention
No intervention
Arm Description
5 out of the 25 participating primary care sites are randomly assigned to any of the 5 steps. The ICOPE intervention is implemented after a pre interventional period of 3-15 months. The intervention is implemented during 8 weeks. The length of the post interventional period is 11-23 months.
Standard of care offered to all patients.
Outcomes
Primary Outcome Measures
Percentage of patients with high initial pain scores (≥6) who experience a 30% reduction in scores
Percentage of patients with high initial pain scores (≥6) who experience a 30% reduction in scores
Increase diversity of recommended pain treatments
More types of treatment are represented in patient's treatment plan. In I-COPE smartset pain treatments are grouped into 4 types: self-management, referrals to specialists, non-opioid medications, and opioid medications.
Decrease higher-risk pain treatments
Discontinuation of opioid/Beer's Criteria medications or decrease in daily milligram equivalents of opioid/Beer's Criteria medications.
Secondary Outcome Measures
Change in pain scores among older adults with and without chronic pain diagnoses and high initial pain scores
Change in pain scores among older adults with and without chronic pain diagnoses and high initial pain scores
Increase in guideline concordant opioid prescriptions
Increase in naloxone prescribing in patients with >50mg equivalents of opioids or OUD; Increase in the number of annual drug screens in patient with chronic opioid use; Decrease in co-prescribing of opioids and benzodiazepines
Decrease in percentage of patients prescribed each high-risk treatments
High-risk treatments are defined as opioids and Beer's criteria medications
Increase in percentage of patients prescribed each low-risk treatments
Low-risk treatments include all pain treatments except opioids and Beer's criteria medications.
Percentage of eligible patients who receive an I-COPE action plan
Percentage of eligible patients who receive an I-COPE action plan
Percentage of physicians who use the I-COPE program
Percentage of physicians in study sites who use the I-COPE program
Percentage of clinics who use the I-COPE program
Percentage of clinics who successfully implement the I-COPE program
Full Information
NCT ID
NCT04878562
First Posted
May 4, 2021
Last Updated
October 29, 2021
Sponsor
University of Chicago
Collaborators
Agency for Healthcare Research and Quality (AHRQ), ACCESS Community Health Network
1. Study Identification
Unique Protocol Identification Number
NCT04878562
Brief Title
I-COPE Study: Opioid Use and Pain Management in Older Adults
Acronym
I-COPE
Official Title
Improving Chicago Older Adult Opioid and Pain Management Through Patient-Centered Clinical Decision Support and Project ECHO
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
June 3, 2021 (Actual)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Chicago
Collaborators
Agency for Healthcare Research and Quality (AHRQ), ACCESS Community Health Network
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Adults over 65 years of age are at higher risk of experiencing chronic pain and adverse events from opioids and opioid use disorder (OUD). Older adults are more likely to inadequately report their pain due to age-related health, which may lead to undertreatment of pain. In the last two decades, opioid prescriptions to treat chronic pain among older adults increased at a rate of nine times what it was previously. This surge is accompanied with a drastic increase of older adults visiting emergency departments due to opioid abuse, misuse, overdose, and addictions to heroin and cocaine. In consequence, chronic pain, opioids, and OUD have become a major crisis in the United States among older adults. The I-COPE program is an intervention that offers providers a set of smart tools for a more effective and efficient geriatric pain, opioid, and OUD management. The aim of the I-COPE program is to evaluate integration of shared decision-making, patient-centered clinical decision support tools, and Project ECHO® to address the critical need to integrate effective treatment for older adults with chronic pain, opioid use, and OUD. Patient-centered clinical decision support (PCCDS) tools provide clinicians with information presented at the right time and tailored to the individual patient, improving communications, care, and patient-provider satisfaction. Shared decision making (SDM) is a highly effective collaborative framework when there are many choices and there is uncertainty about the optimal treatment choice. Project ECHO® is a tested model for delivery of subspecialized medical knowledge to community clinicians. The research into these strategies is supported by the Agency for Healthcare Research and Quality (AHRQ) through the opioid action plan (OAP) initiative. Based on the survey responses the PCCDS will develop a list of pain treatments that are preferable for older adults to use, based on their individual histories. From the PCCDS, an individualized patient action plan will be generated. The action plan will be clearly laid out, use patient-centered language at an ≤ 6th grade level, and simple graphics. It will feature the patient-reported overall goal, current pain rating and pain goal, as well as provide information on changes made to the chronic pain treatment plan. Information about signs of opioid side effects, misuse and opioid overdoses will be included for patients who are taking opioids, as well as instructions for naloxone administration.
Detailed Description
I-COPE program intervention includes four components: patient survey, geriatric PCCDS tool, patient action plan, and provider education.
Patient survey. Three days before each of their scheduled PCP visits, patients will be asked to complete a survey during electronic check-in. If patients have not completed the questionnaire when they arrive on the day of their appointment, they will be asked by the patient services representatives to complete it in the waiting area on paper or using a tablet, or by the medical assistant to complete it during patient triage. In addition to the I-COPE survey patients will be screened for depression and drug abuse. Medical assistants will be trained to enter their responses into the EHR. A caregiver may help the patient complete the questionnaire. Responses will be saved in the patient's medical record and accessible to their care team.
Geriatric PCCDS tool. Information from the patient questionnaire and the EHR will be used to automatically generate a passive alert (best practice advisory) and a tailored smart set which PCPs can open during the visit. The alert will be triggered if a patient responds that they want to discuss pain at their visit or if they screen positive for a possible substance use disorder. The PCCDS was designed with a set of decision rules based on AGS and CDC guidelines for chronic pain and opioids. The PCCDS tool features five sections: All patients (self-management strategies), Oral non-opioid medications, Acute-on-chronic pain only, Opioid medications, and OUD treatment. The PCCDS shows which treatment options are recommended, not recommended, or contraindicated based on the patient's history, comorbidities, and preferences. For instance, if a patient screens positive for depression the Antidepressants smartgroup within the Oral non-opioid medications section will be open and labelled as recommended. Alternative versions of other smartgroups exist for patients with chronic kidney disease of various stages, presence of certain medication, and results of the drug abuse screening. The PCCDS tool also includes links to a conversation tool and patient self-management education tools. The PCCDS tool may be accessed by a provider in cases where patient did not complete the survey.
Patient action plan. At the end of the visit, a personalized action plan will be generated for patients featuring their pain rating and goal, the treatment plan they agreed upon with their PCP, and relevant educational materials. The action plan will be clearly laid out using patient-centered language, maximum 6th grade reading level, and simple graphics. It will be printed out as a part of the after-visit summary.
Provider education. PCPs may opt into an intensive Project ECHO course that offers more geriatric clinical content and EHR updates with real-word cases. Project ECHO (Extension for Community Health Outcomes) is an innovative workforce development model for expanding primary care capacity in underserved communities. It uses videoconferencing technology to "telementor" community-based clinicians via didactic education, group problem solving with actual cases brought by clinicians, and expert advice on implementing best practices. Project ECHO® is possibly a cost-effective strategy for improving clinician competence and behaviors, while likely improving patient outcomes. The curriculum will be delivered in 8-weekly hour-long sessions. Each session will include didactic topics delivered by an interdisciplinary team of content experts, and two 15-minute problem-solving exercises using real-world cases brought by participating PCPs. PCPs will review how they can use the I-COPE Program toolkit with each case. Didactic content will include a walkthrough of the PCCDS and education on the demographics of pain and OUD, special considerations for pain management (e.g., cognitive impairment, functional impairment, social determinants, and caregivers), principles of SDM and assessing patient preferences, pharmacology and pain medications, non-pharmacologic pain management options, and recognition and management of OUD. The abridged version of the ECHO training will be made available online for PCPs to access on their own time if needed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain, Opioids, Opioid-use Disorder
Keywords
older adults, electronic health record, chronic pain, opioid use disorder
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
We will conduct a nonhybrid pragmatic implementation-effectiveness stepped wedge cluster-randomized study in which clinics will be the randomized clusters.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
3000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
I-COPE Intervention
Arm Type
Experimental
Arm Description
5 out of the 25 participating primary care sites are randomly assigned to any of the 5 steps. The ICOPE intervention is implemented after a pre interventional period of 3-15 months. The intervention is implemented during 8 weeks. The length of the post interventional period is 11-23 months.
Arm Title
No intervention
Arm Type
No Intervention
Arm Description
Standard of care offered to all patients.
Intervention Type
Behavioral
Intervention Name(s)
I-COPE
Intervention Description
The patient survey will be sent out via MyChart 3 days before the visit. It asks about current pain, goals, treatment history, treatment preferences, and health status. Alternatively, patients will be asked to compete a survey in clinic on paper or a tablet. The surveys will be identical, except screening for screening for depression and opioid use will depend on the availability of previous scores. Survey and the EHR will help auto-generate best practice advisories (BPAs) and a tailored smart set. The smartset is based on AGS and CDC guidelines for chronic pain and opioids. It shows which treatment options are not recommended based on the patient's history, comorbidities, and preferences. The smartset also includes links to decision aid and patient education tools. Personalized action plan will be created with pain rating and goal, treatment plan, and relevant tips and educational materials. Action plan will be clearly laid out using max 6 grade reading level, and simple graphics.
Primary Outcome Measure Information:
Title
Percentage of patients with high initial pain scores (≥6) who experience a 30% reduction in scores
Description
Percentage of patients with high initial pain scores (≥6) who experience a 30% reduction in scores
Time Frame
6 months
Title
Increase diversity of recommended pain treatments
Description
More types of treatment are represented in patient's treatment plan. In I-COPE smartset pain treatments are grouped into 4 types: self-management, referrals to specialists, non-opioid medications, and opioid medications.
Time Frame
6 months
Title
Decrease higher-risk pain treatments
Description
Discontinuation of opioid/Beer's Criteria medications or decrease in daily milligram equivalents of opioid/Beer's Criteria medications.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change in pain scores among older adults with and without chronic pain diagnoses and high initial pain scores
Description
Change in pain scores among older adults with and without chronic pain diagnoses and high initial pain scores
Time Frame
6 months
Title
Increase in guideline concordant opioid prescriptions
Description
Increase in naloxone prescribing in patients with >50mg equivalents of opioids or OUD; Increase in the number of annual drug screens in patient with chronic opioid use; Decrease in co-prescribing of opioids and benzodiazepines
Time Frame
6 months
Title
Decrease in percentage of patients prescribed each high-risk treatments
Description
High-risk treatments are defined as opioids and Beer's criteria medications
Time Frame
6 months
Title
Increase in percentage of patients prescribed each low-risk treatments
Description
Low-risk treatments include all pain treatments except opioids and Beer's criteria medications.
Time Frame
6 months
Title
Percentage of eligible patients who receive an I-COPE action plan
Description
Percentage of eligible patients who receive an I-COPE action plan
Time Frame
6 months
Title
Percentage of physicians who use the I-COPE program
Description
Percentage of physicians in study sites who use the I-COPE program
Time Frame
6 months
Title
Percentage of clinics who use the I-COPE program
Description
Percentage of clinics who successfully implement the I-COPE program
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age over 65 years AND
receives care at a participating clinical site AND
history of chronic pain AND/OR
opioid prescription in the last 28 days AND/OR
history of opioid use disorder AND/OR
Exclusion Criteria:
-
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ainur Kagarmanova, MS
Phone
5742865712
Email
akagarmanova@medicine.bsd.uchicago.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Erin Staab, MPH
Phone
5072619859
Email
estaab@medicine.bsd.uchicago.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mim Ari, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Neda Laiteerapong, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Katherine Thompson, MD
Organizational Affiliation
University of Chicago
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Chicago Medicine
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60637
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ainur Kagarmanova, MS
Phone
574-286-5712
Email
akagarmanova@medicine.bsd.uchicago.edu
Facility Name
Access Community Health Network
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60661
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Danielle Lazar
Email
danielle.lazar@achn.net
First Name & Middle Initial & Last Name & Degree
Hiba Abbas
Email
hiba.abbas@achn.net
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
This is a clinic-level intervention study. Research team will only receive a limited data set with no individual participant data.
Citations:
PubMed Identifier
20136170
Citation
Gianni W, Ceci M, Bustacchini S, Corsonello A, Abbatecola AM, Brancati AM, Assisi A, Scuteri A, Cipriani L, Lattanzio F. Opioids for the treatment of chronic non-cancer pain in older people. Drugs Aging. 2009 Dec;26 Suppl 1:63-73. doi: 10.2165/11534670-000000000-00000.
Results Reference
background
PubMed Identifier
19573219
Citation
American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009 Aug;57(8):1331-46. doi: 10.1111/j.1532-5415.2009.02376.x. Epub 2009 Jul 2. No abstract available.
Results Reference
background
PubMed Identifier
23420266
Citation
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P; British Geriatric Society. Guidance on the management of pain in older people. Age Ageing. 2013 Mar;42 Suppl 1:i1-57. doi: 10.1093/ageing/afs200.
Results Reference
background
PubMed Identifier
28352631
Citation
Guerriero F. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases. 2017 Mar 16;5(3):73-81. doi: 10.12998/wjcc.v5.i3.73.
Results Reference
background
PubMed Identifier
25678441
Citation
West NA, Severtson SG, Green JL, Dart RC. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend. 2015 Apr 1;149:117-21. doi: 10.1016/j.drugalcdep.2015.01.027. Epub 2015 Jan 31.
Results Reference
background
PubMed Identifier
25581257
Citation
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559.
Results Reference
background
PubMed Identifier
24281287
Citation
Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? Clin J Pain. 2014 Aug;30(8):654-62. doi: 10.1097/01.ajp.0000435447.96642.f4.
Results Reference
background
PubMed Identifier
21084724
Citation
Wu LT, Blazer DG. Illicit and nonmedical drug use among older adults: a review. J Aging Health. 2011 Apr;23(3):481-504. doi: 10.1177/0898264310386224. Epub 2010 Nov 17.
Results Reference
background
PubMed Identifier
30384321
Citation
Huhn AS, Strain EC, Tompkins DA, Dunn KE. A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder. Drug Alcohol Depend. 2018 Dec 1;193:142-147. doi: 10.1016/j.drugalcdep.2018.10.002. Epub 2018 Oct 18.
Results Reference
background
PubMed Identifier
30863796
Citation
Carter MW, Yang BK, Davenport M, Kabel A. Increasing Rates of Opioid Misuse Among Older Adults Visiting Emergency Departments. Innov Aging. 2019 Mar 7;3(1):igz002. doi: 10.1093/geroni/igz002. eCollection 2019 Jan.
Results Reference
background
PubMed Identifier
25037298
Citation
Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014 Aug;30(3):629-54. doi: 10.1016/j.cger.2014.04.008. Epub 2014 Jun 12.
Results Reference
background
PubMed Identifier
12949852
Citation
Schultz SK, Arndt S, Liesveld J. Locations of facilities with special programs for older substance abuse clients in the US. Int J Geriatr Psychiatry. 2003 Sep;18(9):839-43. doi: 10.1002/gps.994.
Results Reference
background
PubMed Identifier
35897111
Citation
Kagarmanova A, Sparkman H, Laiteerapong N, Thompson K, Rosul L, Lazar D, Staab E, Wan W, Kass A, Ari M. Improving the management of chronic pain, opioid use, and opioid use disorder in older adults: study protocol for I-COPE study. Trials. 2022 Jul 27;23(1):602. doi: 10.1186/s13063-022-06537-w.
Results Reference
derived
Learn more about this trial
I-COPE Study: Opioid Use and Pain Management in Older Adults
We'll reach out to this number within 24 hrs